Vitamin D... Panacea
Some consumers and doctors are becoming convinced vitamin D can help reduce the risk of a long list of diseases, despite a lack of gold-standard research proving it.
A growing body of research suggests that supplements of the so-called sunshine vitamin may reduce the risk of multiple sclerosis, diabetes and breast and prostate cancers.
But much of the research comes from observational studies rather than placebo-controlled trials -- the highest standard in health research. Such rigorous trials to prove vitamin D's preventive benefits are expensive, and since vitamins can't be patented, pharmaceutical companies have no financial incentive to do the research.
- Historic Myanmar peace conference aims to end decades of violence
- Myanmar begins a historic peace conference on Wednesday, with the aim of ending decades of violence between the Myanmar Army and ethnic armed groups that has claimed thousands of lives.
- Justin Trudeau suggests China improve its image by tightening ties with Canada video
- Justin Trudeau delivered a message to powerful business leaders in Beijing on Tuesday, shortly after his plane touched down: China needs a little more Canada.
- State funeral in Italy honours quake victims
- Construction crews work through the rain in Italy's earthquake zone to build a tent complex to host a state funeral, as prosecutors took preliminary measures to sequester buildings that crumbled despite being renovated with public anti-seismic funds.
- 'I have no alternative': Palestinian teen sneaks into Israel to join 25,000 illegal workers video
- Israeli authorities say they plan to clamp down on some 25,000 Palestinians working inside Israel illegally. But the illegal workers continue to make their way in. See how two young Palestinian make the dangerous journey.
- EU rules Apple must pay up to 13B euros in back taxes
- The European Union says Ireland has given illegal tax benefits worth up to 13 billion euros ($14.5 billion US) to Apple Inc. and must now recover the unpaid back taxes from the U.S. technology company, plus interest.